{"id":51179,"date":"2026-06-26T11:29:09","date_gmt":"2026-06-26T09:29:09","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51179"},"modified":"2026-06-21T09:33:51","modified_gmt":"2026-06-21T07:33:51","slug":"pinealon-a-jine-peptidy-srovnani-s-epitalonem-semaxem-cerebrolysinem-ss-31-a-tesamorelinem","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/cs\/pinealon-a-inne-peptydy-porownanie-z-epitalon-semax-cerebrolysin-ss-31-i-tesamorelin\/","title":{"rendered":"Pinealon a dal\u0161\u00ed peptidy: Srovn\u00e1n\u00ed s Epitalonem, Semaxem, Cerebrolysinem, SS-31 a Tesamorelinem"},"content":{"rendered":"<p>&nbsp;<\/p>\n<h2>Pinealon a jin\u00e9 peptidy<\/h2>\n<p>S rostouc\u00edm z\u00e1jmem o peptidov\u00e9 intervence je Pinealon \u010dasto srovn\u00e1v\u00e1n s n\u011bkolika zn\u00e1m\u00fdmi peptidy, v\u010detn\u011b Epitalonu, Semaxu, Cerebrolysinu, SS-31 a Tesamorelinu. A\u010dkoli jsou tyto slou\u010deniny \u010dasto diskutov\u00e1ny ve stejn\u00e9m kontextu, p\u0159edstavuj\u00ed v\u00fdznamn\u00e9 rozd\u00edly ve sv\u00e9 molekul\u00e1rn\u00ed struktu\u0159e, biologick\u00fdch c\u00edlech, navrhovan\u00fdch mechanismech \u00fa\u010dinku a oblastech v\u011bdeck\u00e9ho v\u00fdzkumu.<\/p>\n<h3>Pinealon proti Epitalonu<\/h3>\n<p>Pinealon i Epitalon jsou bioregula\u010dn\u00ed peptidy vyvinut\u00e9 Vladimirem Khavinsonem a jeho kolegy. Oba jsou \u010dasto diskutov\u00e1ny v kontextu zdrav\u00e9ho st\u00e1rnut\u00ed a v\u00fdzkumu dlouhov\u011bkosti. Navzdory t\u011bmto podobnostem se v\u0161ak jedn\u00e1 o odli\u0161n\u00e9 molekuly. Pinealon je tripeptid tvo\u0159en\u00fd kyselinou glutamovou, kyselinou asparagovou a argininem (Glu-Asp-Arg; EDR), zat\u00edmco Epitalon je tetrapeptid slo\u017een\u00fd z alaninu, kyseliny glutamov\u00e9, kyseliny asparagov\u00e9 a glycinu (Ala-Glu-Asp-Gly) (1,2).<\/p>\n<p>V\u00fdzkum Pinealonu se zam\u011b\u0159oval p\u0159edev\u0161\u00edm na neuroprotekci, kognitivn\u00ed funkce, regulaci oxida\u010dn\u00edho stresu, p\u0159e\u017eit\u00ed neuron\u016f a na neurologick\u00e9 zm\u011bny souvisej\u00edc\u00ed s v\u011bkem (3\u20138). Experiment\u00e1ln\u00ed studie uk\u00e1zaly, \u017ee Pinealon sni\u017euje hladiny reaktivn\u00edch forem kysl\u00edku (ROS), zlep\u0161uje \u017eivotaschopnost neuron\u016f, zvy\u0161uje expresi serotoninu a chr\u00e1n\u00ed nervov\u00e9 bu\u0148ky p\u0159ed r\u016fzn\u00fdmi formami bun\u011b\u010dn\u00e9ho stresu (4\u20138).<\/p>\n<p>Z kolei badania nad Epitalonem skupiaj\u0105 si\u0119 g\u0142\u00f3wnie na biologii starzenia, aktywno\u015bci telomerazy, regulacji melatoninu, funkcjonov\u00e1n\u00ed cirkadi\u00e1nn\u00edho rytmu a mechanismech spojen\u00fdch s dlouhov\u011bkost\u00ed. A\u010dkoli oba peptidy jsou za\u0159azeny mezi geroprotektivn\u00ed bioregula\u010dn\u00ed l\u00e1tky, Pinealon je obvykle vn\u00edm\u00e1n jako peptid s v\u00edce neurocentrick\u00fdm \u00fa\u010dinkem, zat\u00edmco Epitalon je \u010dast\u011bji spojov\u00e1n s celkov\u00fdmi anti-agingov\u00fdmi studiemi a funkc\u00ed epif\u00fdzy.<\/p>\n<p>Jeliko\u017e oba peptidy mohou p\u016fsobit na odli\u0161n\u00e9 biologick\u00e9 dr\u00e1hy, n\u011bkte\u0159\u00ed v\u00fdzkumn\u00edci a u\u017eivatel\u00e9 peptid\u016f pova\u017euj\u00ed Pinealon a Epitalon za potenci\u00e1ln\u011b dopl\u0148uj\u00edc\u00ed se slou\u010deniny. Kontrolovan\u00e9 klinick\u00e9 studie hodnot\u00edc\u00ed jejich sou\u010dasn\u00e9 u\u017e\u00edv\u00e1n\u00ed jsou v\u0161ak velmi omezen\u00e9 a dosud nebyly provedeny \u017e\u00e1dn\u00e9 rozs\u00e1hl\u00e9 studie na lidech potvrzuj\u00edc\u00ed bezpe\u010dnost nebo \u00fa\u010dinnost tohoto p\u0159\u00edstupu.<\/p>\n<h3>Pinealon vs Semax<\/h3>\n<p>Pinealon a Semax jsou \u010dasto porovn\u00e1v\u00e1ny, proto\u017ee oba byly zkoum\u00e1ny pro neuroprotekci a podporu kognitivn\u00edch funkc\u00ed. Pat\u0159\u00ed v\u0161ak do zcela odli\u0161n\u00fdch rodin peptid\u016f.<\/p>\n<p>Pinealon je kr\u00e1tk\u00fd bioregula\u010dn\u00ed tripeptid (Glu-Asp-Arg), zat\u00edmco Semax je syntetick\u00fd analog adrenokortikotropn\u00edho hormonu ACTH(4-10), vyvinut\u00fd v Rusku pro neurologick\u00e9 aplikace (9,10).<\/p>\n<p>Dostupn\u00e9 \u00fadaje nazna\u010duj\u00ed, \u017ee Pinealon vyvol\u00e1v\u00e1 mnoho sv\u00fdch biologick\u00fdch \u00fa\u010dink\u016f prost\u0159ednictv\u00edm regulace oxida\u010dn\u00edho stresu, epigenetick\u00fdch mechanism\u016f, modulace genov\u00e9 exprese, interakce s dr\u00e1hami souvisej\u00edc\u00edmi se serotoninem a podpory p\u0159e\u017eit\u00ed neuron\u016f (4\u20138). Na druh\u00e9 stran\u011b se v\u00fdzkum Semaxu zam\u011b\u0159oval p\u0159edev\u0161\u00edm na neurotrofn\u00ed aktivitu, modulaci neurotransmiterov\u00fdch syst\u00e9m\u016f, neuroprotekci po ischemick\u00fdch l\u00e9z\u00edch a zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed (9,10).<\/p>\n<p>A\u010dkoli jsou oba peptidy zkoum\u00e1ny pro sv\u00e9 \u00fa\u010dinky na zdrav\u00ed mozku a kognitivn\u00ed funkce, v\u00fdzkumy Semaxu zd\u016fraz\u0148uj\u00ed p\u0159edev\u0161\u00edm neurotrofick\u00e9 \u00fa\u010dinky a \u00fa\u010dinky spojen\u00e9 s neurotransmitery, zat\u00edmco v\u00fdzkumy Pinealonu se v\u00edce zam\u011b\u0159uj\u00ed na ochranu bun\u011bk, biologii st\u00e1rnut\u00ed, sni\u017eov\u00e1n\u00ed oxida\u010dn\u00edho stresu a epigenetickou regulaci.<\/p>\n<p>V sou\u010dasn\u00e9 dob\u011b nebyly provedeny \u017e\u00e1dn\u00e9 p\u0159\u00edm\u00e9 klinick\u00e9 studie porovn\u00e1vaj\u00edc\u00ed Pinealon a Semax u lid\u00ed.<\/p>\n<h3>Pinealon vs Cerebrolysin<\/h3>\n<p>Cerebrolysin se v\u00fdrazn\u011b li\u0161\u00ed od Pinealonu jak slo\u017een\u00edm, tak slo\u017eitost\u00ed. Pinealon se skl\u00e1d\u00e1 z jedin\u00e9ho syntetick\u00e9ho tripeptidu, zat\u00edmco Cerebrolysin je komplexn\u00ed sm\u011bs n\u00edzkomolekul\u00e1rn\u00edch neuropeptid\u016f a aminokyselinov\u00fdch fragment\u016f z\u00edskan\u00fdch z mozkov\u00e9 tk\u00e1n\u011b prasat.<\/p>\n<p>V\u00fdzkum Cerebrolysinu se zam\u011b\u0159oval p\u0159edev\u0161\u00edm na rekonvalescenci po c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhod\u011b, traumatick\u00e9m po\u0161kozen\u00ed mozku, vaskul\u00e1rn\u00ed demenci a Alzheimerov\u011b chorob\u011b. Naopak v\u00fdzkum Pinealonu se t\u00fdkal p\u0159edev\u0161\u00edm ochrany neuron\u016f, odolnosti v\u016f\u010di oxida\u010dn\u00edmu stresu, kognitivn\u00edch funkc\u00ed a zdrav\u00e9ho st\u00e1rnut\u00ed (3\u20138).<\/p>\n<p>Podstawowa r\u00f3\u017cnica mi\u0119dzy tymi zwi\u0105zkami polega na skali dost\u0119pnych danych klinicznych. Cerebrolysin by\u0142 oceniany w znacznie wi\u0119kszych programach bada\u0144 klinicznych ni\u017c Pinealon. Dane dotycz\u0105ce Pinealon s\u0105 nadal ograniczone i pochodz\u0105 g\u0142\u00f3wnie z bada\u0144 przedklinicznych oraz stosunkowo niewielkich bada\u0144 klinicznych.<\/p>\n<p>P\u0159esto\u017ee jsou ob\u011b slou\u010deniny zkoum\u00e1ny pro sv\u00e9 neuroprotektivn\u00ed \u00fa\u010dinky, p\u016fsob\u00ed prost\u0159ednictv\u00edm odli\u0161n\u00fdch biologick\u00fdch mechanism\u016f a nem\u011bly by b\u00fdt zam\u011b\u0148ov\u00e1ny.<\/p>\n<h3>Pinealon vs SS-31<\/h3>\n<p>SS-31 (elamipretide) je peptid c\u00edlen\u00fd na mitochondrie, vyvinut\u00fd k ochran\u011b mitochondri\u00e1ln\u00edch funkc\u00ed a omezen\u00ed oxida\u010dn\u00edho po\u0161kozen\u00ed v bu\u0148k\u00e1ch. Na rozd\u00edl od Pinealonu, kter\u00fd zd\u00e1 se ovliv\u0148uje genovou expresi, p\u0159e\u017eit\u00ed neuron\u016f, synt\u00e9zu serotoninu a bun\u011b\u010dn\u00e9 sign\u00e1ln\u00ed dr\u00e1hy, SS-31 p\u016fsob\u00ed prim\u00e1rn\u011b na mitochondri\u00e1ln\u00ed membr\u00e1ny a bun\u011b\u010dnou bioenergetiku.<\/p>\n<p>Oba peptidy byly zkoum\u00e1ny z hlediska jejich schopnosti sni\u017eovat oxida\u010dn\u00ed stres. Bylo prok\u00e1z\u00e1no, \u017ee Pinealon omezuje akumulaci reaktivn\u00edch forem kysl\u00edku a sni\u017euje po\u0161kozen\u00ed bun\u011bk za podm\u00ednek oxida\u010dn\u00edho stresu (4,5), zat\u00edmco studie SS-31 se zam\u011b\u0159ovaly na zlep\u0161en\u00ed mitochondri\u00e1ln\u00ed funkce a sn\u00ed\u017een\u00ed po\u0161kozen\u00ed vypl\u00fdvaj\u00edc\u00edho z jejich dysfunkce.<\/p>\n<p>V sou\u010dasn\u00e9 dob\u011b neprob\u011bhly \u017e\u00e1dn\u00e9 p\u0159\u00edm\u00e9 studie porovn\u00e1vaj\u00edc\u00ed Pinealon a SS-31.<\/p>\n<h3>Pinealon vs. Tesamorelin<\/h3>\n<p>Pinealon a Tesamorelin pat\u0159\u00ed do naprosto odli\u0161n\u00fdch kategori\u00ed peptid\u016f a byly zkoum\u00e1ny pro zcela odli\u0161n\u00e9 biologick\u00e9 \u00fa\u010dely.<\/p>\n<p>Pinealon je neuroregula\u010dn\u00ed bioregula\u010dn\u00ed tripeptid, zkouman\u00fd p\u0159edev\u0161\u00edm v kontextu neuroprotekce, kognitivn\u00edch funkc\u00ed, regulace oxida\u010dn\u00edho stresu a zdrav\u00e9ho st\u00e1rnut\u00ed (3\u20138). Tesamorelin je naproti tomu analogem hormonu uvol\u0148uj\u00edc\u00edho r\u016fstov\u00fd hormon (GHRH), kter\u00fd stimuluje sekreci endogenn\u00edho r\u016fstov\u00e9ho hormonu a zvy\u0161uje produkci inzul\u00ednov\u00e9ho r\u016fstov\u00e9ho faktoru-1 (IGF-1).<\/p>\n<p>V\u00fdzkum Tesamorelinu se prim\u00e1rn\u011b zam\u011b\u0159oval na redukci viscer\u00e1ln\u00edho tuku, slo\u017een\u00ed t\u011bla, metabolick\u00e9 zdrav\u00ed a fyziologii souvisej\u00edc\u00ed s r\u016fstov\u00fdm hormonem. Na druhou stranu, v\u00fdzkum Pinealonu se soust\u0159edil na neuroprotekci, procesy u\u010den\u00ed a pam\u011bti, expresi serotoninu a bun\u011b\u010dn\u00e9 mechanismy souvisej\u00edc\u00ed se st\u00e1rnut\u00edm.<\/p>\n<p>Vzhledem k t\u011bmto v\u00fdznamn\u00fdm mechanistick\u00fdm rozd\u00edl\u016fm ot\u00e1zka \u201eTesamorelin nebo Pinealon?\u201d nep\u0159edstavuje p\u0159\u00edm\u00e9 srovn\u00e1n\u00ed. Oba peptidy jsou zkoum\u00e1ny pro r\u016fzn\u00e9 v\u011bdeck\u00e9 \u00fa\u010dely a ovliv\u0148uj\u00ed odli\u0161n\u00e9 fyziologick\u00e9 syst\u00e9my.<\/p>\n<h2>V\u0161eobecn\u00e1 v\u011bdeck\u00e1 perspektiva<\/h2>\n<p>Pinealon vynik\u00e1 mezi mnoha \u010dasto zmi\u0148ovan\u00fdmi peptidy kombinac\u00ed neuroprotektivn\u00edch, antioxida\u010dn\u00edch, epigenetick\u00fdch a geroprotektivn\u00edch vlastnost\u00ed. Sou\u010dasn\u00e9 \u00fadaje nazna\u010duj\u00ed, \u017ee Pinealon m\u016f\u017ee podporovat p\u0159e\u017eit\u00ed neuron\u016f, omezovat oxida\u010dn\u00ed stres, ovliv\u0148ovat sign\u00e1ln\u00ed dr\u00e1hy spojen\u00e9 se serotoninem a regulovat bun\u011b\u010dn\u00e9 funkce souvisej\u00edc\u00ed se st\u00e1rnut\u00edm a neuroprotekc\u00ed.<\/p>\n<p>Nicm\u00e9n\u011b p\u0159\u00edm\u00e9 klinick\u00e9 studie porovn\u00e1vaj\u00edc\u00ed Pinealon s jin\u00fdmi peptidy z\u016fst\u00e1vaj\u00ed velmi omezen\u00e9. V d\u016fsledku toho nelze v sou\u010dasn\u00e9 dob\u011b u\u010dinit jednozna\u010dn\u00e9 z\u00e1v\u011bry t\u00fdkaj\u00edc\u00ed se relativn\u00ed \u00fa\u010dinnosti, bezpe\u010dnosti nebo v\u00fdhod jednotliv\u00fdch slou\u010denin. K lep\u0161\u00edmu charakterizov\u00e1n\u00ed podobnost\u00ed a rozd\u00edl\u016f mezi t\u011bmito peptidy jsou zapot\u0159eb\u00ed dal\u0161\u00ed, dob\u0159e navr\u017een\u00e9 studie s \u00fa\u010dast\u00ed \u010dlov\u011bka.<\/p>\n<h3>Zastrze\u017cenie<\/h3>\n<p>Obsah je ur\u010den v\u00fdhradn\u011b pro vzd\u011bl\u00e1vac\u00ed a informa\u010dn\u00ed \u00fa\u010dely a nem\u011bl by b\u00fdt interpretov\u00e1n jako l\u00e9ka\u0159sk\u00e1 rada, diagn\u00f3za, l\u00e9\u010dba ani odborn\u00e9 doporu\u010den\u00ed. Pinealon, Epitalon, Semax, Cerebrolysin, SS-31 a Tesam \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03bf se v\u00fdznamn\u011b li\u0161\u00ed svou strukturou, mechanizmy \u00fa\u010dinku a oblastmi v\u011bdeck\u00e9ho v\u00fdzkumu. Pinealon nebyl schv\u00e1len americk\u00fdm \u00da\u0159adem pro kontrolu potravin a l\u00e9\u010div (FDA), Evropskou agenturou pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) ani v\u011bt\u0161inou ostatn\u00edch regula\u010dn\u00edch org\u00e1n\u016f pro l\u00e9\u010dbu neurologick\u00fdch poruch, kognitivn\u00edch poruch, onemocn\u011bn\u00ed souvisej\u00edc\u00edch se st\u00e1rnut\u00edm nebo jak\u00fdchkoli jin\u00fdch l\u00e9ka\u0159sk\u00fdch indikac\u00ed. Zna\u010dn\u00e1 \u010d\u00e1st dostupn\u00fdch \u00fadaj\u016f poch\u00e1z\u00ed z preklinick\u00fdch studi\u00ed a omezen\u00fdch studi\u00ed na lidech. Jsou zapot\u0159eb\u00ed dal\u0161\u00ed, dob\u0159e navr\u017een\u00e9 klinick\u00e9 studie, aby se l\u00e9pe stanovila \u00fa\u010dinnost, bezpe\u010dnost a dlouhodob\u00e9 \u00fa\u010dinky t\u011bchto peptid\u016f a aby se ur\u010dilo, zda existuj\u00ed mezi nimi klinicky v\u00fdznamn\u00e9 rozd\u00edly.<\/p>\n<h4>Odkazy<\/h4>\n<ol>\n<li data-start=\"16\" data-end=\"126\"><span style=\"font-size: 10pt;\">Chemick\u00e9 a slo\u017een\u00ed dat Pinealonu (EDR peptid).<\/span><br data-start=\"74\" data-end=\"77\" \/><span style=\"font-size: 10pt;\">Wikipedie <a class=\"decorated-link\" href=\"https:\/\/en.wikipedia.org\/wiki\/Pinealon?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"88\" data-end=\"126\">https:\/\/en.wikipedia.org\/wiki\/Pinealon<\/a><\/span><\/li>\n<li data-start=\"128\" data-end=\"546\"><span style=\"font-size: 10pt;\">Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K., &amp; Vanyushin, B. F. (2011). <em data-start=\"211\" data-end=\"383\">Penetrace kr\u00e1tk\u00fdch fluorescen\u010dn\u011b zna\u010den\u00fdch peptid\u016f do j\u00e1dra v bu\u0148k\u00e1ch HeLa a in vitro specifick\u00e1 interakce peptid\u016f s deoxyribooligonucleotidy a DNA<\/em>. <em data-start=\"385\" data-end=\"412\">Biochemie (Moskva), 76<\/em>(11), 1210\u20131219. <a class=\"decorated-link cursor-pointer\" target=\"_new\" rel=\"noopener\" data-start=\"429\" data-end=\"470\">https:\/\/doi.org\/10.1134\/S0006297911110022<\/a><\/span><br data-start=\"470\" data-end=\"473\" \/><span style=\"font-size: 10pt;\">Odkaz na den\u00edk: <a class=\"decorated-link\" href=\"https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"487\" data-end=\"546\">https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022<\/a><\/span><\/li>\n<li data-start=\"548\" data-end=\"892\"><span style=\"font-size: 10pt;\">Meshchaninov, V. N., Tkachenko, E. L., Zharkov, S. V., Gavrilov, I. V., &amp; Katyreva, Y. E. (2015). <em data-start=\"650\" data-end=\"798\">Vliv syntetick\u00fdch peptid\u016f na st\u00e1rnut\u00ed pacient\u016f s chronickou polymorbiditou a syndromem organick\u00e9ho po\u0161kozen\u00ed centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu v remisi<\/em>. <em data-start=\"800\" data-end=\"829\">Pokroky v gerontologii, 28<\/em>(1), 62\u201367.<\/span><br data-start=\"840\" data-end=\"843\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/\" target=\"_new\" rel=\"noopener\" data-start=\"851\" data-end=\"892\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/<\/a><\/span><\/li>\n<li data-start=\"894\" data-end=\"1209\"><span style=\"font-size: 10pt;\">Khavinson, V., Ribakova, Y., et al. (2011). <em data-start=\"942\" data-end=\"1054\">Pinealon zvy\u0161uje \u017eivotaschopnost bun\u011bk potla\u010den\u00edm hladiny voln\u00fdch radik\u00e1l\u016f a aktivac\u00ed prolifera\u010dn\u00edch proces\u016f<\/em>. <em data-start=\"1056\" data-end=\"1083\">Rejuvenation Research, 14<\/em>(5), 517\u2013523. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1089\/rej.2011.1172\" target=\"_new\" rel=\"noopener\" data-start=\"1097\" data-end=\"1134\">https:\/\/doi.org\/10.1089\/rej.2011.1172<\/a><\/span><br data-start=\"1134\" data-end=\"1137\" \/><span style=\"font-size: 10pt;\">Odkaz na den\u00edk: <a class=\"decorated-link\" href=\"https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172\" target=\"_new\" rel=\"noopener\" data-start=\"1151\" data-end=\"1209\">https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172<\/a><\/span><\/li>\n<li data-start=\"1211\" data-end=\"1608\"><span style=\"font-size: 10pt;\">Arutjunjan, A. V., Kozinov\u00e1, L. S., Stvolinskij, S. L., Bulyginov\u00e1, E. R., Ma\u0161kinov\u00e1, A. P., &amp; Chavinson, V. K. (2012). <em data-start=\"1329\" data-end=\"1401\">Pinealon chr\u00e1n\u00ed potkany po narozen\u00ed p\u0159ed prenat\u00e1ln\u00ed hyperhomocysteinemi\u00ed<\/em>. <em data-start=\"1403\" data-end=\"1444\">International Journal of Peptides, 2012<\/em>, 109757. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1155\/2012\/109757\" target=\"_new\" rel=\"noopener\" data-start=\"1454\" data-end=\"1489\">https:\/\/doi.org\/10.1155\/2012\/109757<\/a><\/span><br data-start=\"1489\" data-end=\"1492\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/\" target=\"_new\" rel=\"noopener\" data-start=\"1500\" data-end=\"1541\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/<\/a><\/span><br data-start=\"1541\" data-end=\"1544\" \/><span style=\"font-size: 10pt;\">Cel\u00fd text PMC: <a class=\"decorated-link\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"1559\" data-end=\"1608\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/<\/a><\/span><\/li>\n<li data-start=\"1610\" data-end=\"1957\"><span style=\"font-size: 10pt;\">Khavinson, V. K., Lin\u2019kova, N. S., Tarnovskaya, S. I., Umnov, R. S., Elashkina, E. V., &amp; Durnova, A. O. (2014). <em data-start=\"1726\" data-end=\"1798\">Kr\u00e1tk\u00e9 peptidy stimuluj\u00ed expresi serotoninu v bu\u0148k\u00e1ch mozkov\u00e9 k\u016fry<\/em>. <em data-start=\"1800\" data-end=\"1852\">Bulletin experiment\u00e1ln\u00ed biologie a medic\u00edny, 157<\/em>(1), 77\u201380. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1007\/s10517-014-2496-y\" target=\"_new\" rel=\"noopener\" data-start=\"1864\" data-end=\"1905\">https:\/\/doi.org\/10.1007\/s10517-014-2496-y<\/a><\/span><br data-start=\"1905\" data-end=\"1908\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/\" target=\"_new\" rel=\"noopener\" data-start=\"1916\" data-end=\"1957\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/<\/a><\/span><\/li>\n<li data-start=\"1959\" data-end=\"2332\"><span style=\"font-size: 10pt;\">Kraskovskaya, N. A., Kukanova, E. O., Lin\u2019kova, N. S., Popugaeva, E. A., &amp; Khavinson, V. K. (2017). <em data-start=\"2063\" data-end=\"2171\">Tripeptidy obnovuj\u00ed po\u010det neuron\u00e1ln\u00edch trn\u016f v podm\u00ednk\u00e1ch in vitro modelovan\u00e9ho Alzheimerova onemocn\u011bn\u00ed<\/em>. <em data-start=\"2173\" data-end=\"2225\">Bulletin experiment\u00e1ln\u00ed biologie a medic\u00edny, 163<\/em>(4), 547\u2013550. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1007\/s10517-017-3847-2\" target=\"_new\" rel=\"noopener\" data-start=\"2239\" data-end=\"2280\">https:\/\/doi.org\/10.1007\/s10517-017-3847-2<\/a><\/span><br data-start=\"2280\" data-end=\"2283\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/\" target=\"_new\" rel=\"noopener\" data-start=\"2291\" data-end=\"2332\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/<\/a><\/span><\/li>\n<li data-start=\"2334\" data-end=\"2684\"><span style=\"font-size: 10pt;\">Khavinson, V., Ilina, A., Kraskovskaya, N., Linkova, N., Kolchina, N., Mironova, E., Erofeev, A., &amp; Petukhov, M. (2021). <em data-start=\"2459\" data-end=\"2561\">Neuroprotektivn\u00ed \u00fa\u010dinky tripeptid\u016f \u2013 epigenetick\u00fdch regul\u00e1tor\u016f na my\u0161\u00edm modelu Alzheimerovy choroby<\/em>. <em data-start=\"2563\" data-end=\"2584\">Farmacie, 14<\/em>(6), 515. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.3390\/ph14060515\" target=\"_new\" rel=\"noopener\" data-start=\"2594\" data-end=\"2628\">https:\/\/doi.org\/10.3390\/ph14060515<\/a><\/span><br data-start=\"2628\" data-end=\"2631\" \/><span style=\"font-size: 10pt;\">Odkaz na den\u00edk: <a class=\"decorated-link\" href=\"https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515\" target=\"_new\" rel=\"noopener\" data-start=\"2645\" data-end=\"2684\">https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515<\/a><\/span><\/li>\n<li data-start=\"2686\" data-end=\"2998\"><span style=\"font-size: 10pt;\">Tsai, S. J. (2007). <em data-start=\"2710\" data-end=\"2862\">Semax, analog adrenokortikotropinu (4\u201310), je potenci\u00e1ln\u00ed l\u00e1tka pro l\u00e9\u010dbu poruchy pozornosti s hyperaktivitou a Rettova syndromu.<\/em>. <em data-start=\"2864\" data-end=\"2888\">Medical Hypotheses, 68<\/em>(5), 1144\u20131146. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017\" target=\"_new\" rel=\"noopener\" data-start=\"2904\" data-end=\"2946\">https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017<\/a><\/span><br data-start=\"2946\" data-end=\"2949\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/\" target=\"_new\" rel=\"noopener\" data-start=\"2957\" data-end=\"2998\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/<\/a><\/span><\/li>\n<li data-start=\"3000\" data-end=\"3502\"><span style=\"font-size: 10pt;\">Dolotov, O. V., Karpenko, E. A., Inozemtseva, L. S., Seredenina, T. S., Levitskaya, N. G., Rozyczka, J., Dubynina, E. V., Novosadova, E. V., Andreeva, L. A., Alfeeva, L. Y., Kamensky, A. A., Grivennikov, I. A., Myasoedov, N. F., &amp; Engele, J. (2006). <em data-start=\"3254\" data-end=\"3368\">Semax, analog ACTH(4\u201310) s kognitivn\u00edmi \u00fa\u010dinky, reguluje expresi BDNF a trkB v krys\u00edm hipokampu<\/em>. <em data-start=\"3370\" data-end=\"3392\">V\u00fdzkum mozku, 1117<\/em>(1), 54\u201360. <a class=\"decorated-link\" href=\"https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108\" target=\"_new\" rel=\"noopener\" data-start=\"3404\" data-end=\"3450\">https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108<\/a><\/span><br data-start=\"3450\" data-end=\"3453\" \/><span style=\"font-size: 10pt;\">PubMed: <a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/\" target=\"_new\" rel=\"noopener\" data-start=\"3461\" data-end=\"3502\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/<\/a><\/span><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>&nbsp; Pinealon a dal\u0161\u00ed peptidy Vzhledem k rostouc\u00edmu z\u00e1jmu o intervence zalo\u017een\u00e9 na peptidech je Pinealon \u010dasto srovn\u00e1v\u00e1n s n\u011bkolika zn\u00e1m\u00fdmi peptidy, v\u010detn\u011b Epitalonu, Semaxu,\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[253],"tags":[],"class_list":["post-51179","post","type-post","status-publish","format-standard","hentry","category-kategoria-pinealon","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/51179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/comments?post=51179"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/51179\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/media?parent=51179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/categories?post=51179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/tags?post=51179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}